LG 101506: High-Purity RXR Modulator for Nuclear Receptor Signaling Research

Executive Summary: LG 101506 is a small molecule RXR modulator with 98% purity and a molecular weight of 420.53 g/mol, validated for use in RXR signaling research (APExBIO). It is highly soluble in DMSO (42.05 mg/ml) and ethanol (21.03 mg/ml), and exhibits stability when shipped on blue/dry ice and stored at -20°C. LG 101506 enables precise modulation of RXR activity, facilitating studies in metabolism, nuclear receptor signaling, and immune checkpoint regulation (Zhang et al. 2022). Its use is strictly for scientific research, not for diagnostic or therapeutic applications. This article integrates peer-reviewed evidence and product documentation to guide best practices and clarify limitations.

Biological Rationale

The Retinoid X Receptor (RXR) is a nuclear receptor that forms heterodimers with other nuclear receptors, regulating gene expression involved in metabolism, cell differentiation, and immune function (Zhang et al. 2022). RXR signaling is central to processes such as lipid metabolism, glucose homeostasis, and immune checkpoint control. Dysregulation of RXR pathways has been implicated in metabolic disorders, cancer, and immune evasion mechanisms. Modulating RXR activity with selective ligands like LG 101506 allows researchers to dissect these pathways with high specificity (Rewiring RXR Signaling). This article extends prior analyses by providing up-to-date benchmarks and clarifications for LG 101506’s use in novel disease models.

Mechanism of Action of LG 101506

LG 101506 acts as a modulator of the RXR pathway by binding to the RXR ligand-binding domain. Its chemical structure, (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid, confers selective affinity for RXR, influencing its dimerization and transcriptional activity (APExBIO). Upon binding, LG 101506 alters RXR's ability to regulate gene transcription related to metabolism and immune response. This modulation impacts nuclear receptor crosstalk, affecting genes involved in cellular differentiation, metabolic regulation, and immune checkpoint expression. LG 101506’s mechanism has been leveraged in both metabolic and cancer biology research to model RXR-driven processes (LG 101506 in Nuclear Receptor Research). This article clarifies distinctions between LG 101506 and other RXR ligands in precision and workflow compatibility.

Evidence & Benchmarks

• LG 101506 exhibits 98.00% purity by HPLC, supporting reproducible experimental outcomes (APExBIO).
• Solubility in DMSO is 42.05 mg/ml and in ethanol is 21.03 mg/ml at room temperature, facilitating high-concentration dosing in in vitro assays (APExBIO).
• Modulation of RXR has been shown to impact PD-L1 expression in cancer models, linking RXR signaling to immune checkpoint control (Zhang et al. 2022).
• Proper storage (at -20°C, protected from light and moisture) preserves compound integrity for at least six months (APExBIO).
• LG 101506 enables exploration of RXR crosstalk in metabolism and cancer, offering advantages over less soluble RXR ligands (LG 101506: RXR Modulator Transforming Research).
• Benchmark studies report its utility in modeling immune-cold disease environments such as triple-negative breast cancer (Zhang et al. 2022).

Applications, Limits & Misconceptions

LG 101506 is designed for scientific research in RXR signaling, metabolism regulation, and nuclear receptor-driven disease models. It has been particularly valuable in dissecting mechanisms underlying immune evasion and metabolic dysregulation (LG 101506: Empowering Nuclear Receptor Research). Compared with other RXR ligands, LG 101506 provides enhanced purity and solubility, enabling precise titration and reliable assay results. This article expands on the use-cases discussed in "Precision RXR Modulation" by detailing storage, stability, and compatibility constraints.

Common Pitfalls or Misconceptions

• LG 101506 is not for diagnostic or therapeutic use; it is intended solely for laboratory research (APExBIO).
• Long-term storage of solutions can lead to degradation; use freshly prepared solutions for optimal results.
• Improper storage above -20°C or exposure to moisture/light may compromise compound integrity.
• The compound’s effects are RXR-specific; it does not modulate other nuclear receptors without RXR involvement.
• Results from in vitro studies may not directly translate to in vivo systems without additional validation.

Workflow Integration & Parameters

For experimental workflows, LG 101506 should be dissolved in DMSO or ethanol at recommended concentrations (up to 42.05 mg/ml and 21.03 mg/ml, respectively). Solutions should be prepared fresh and used promptly; avoid repeated freeze-thaw cycles. For shipping, APExBIO provides blue ice or dry ice to preserve stability. Store powder at -20°C in a desiccated environment. LG 101506’s off-white solid form assists with accurate weighing and handling. When modeling RXR signaling, titrate concentrations based on cell type and desired RXR modulation, referencing peer-reviewed protocols and the LG 101506 product page for technical guidance. This workflow integration section updates and clarifies the procedural details compared to earlier summaries.

Conclusion & Outlook

LG 101506 provides a robust, high-purity tool for dissecting RXR pathways in metabolism, cancer, and immune regulation. Its high solubility and validated storage/shipping conditions make it a preferred RXR modulator for translational and mechanistic research. Future studies may expand its use in combinatorial models of immune checkpoint blockade and metabolic disease, but current applications remain strictly research-focused. For technical specifications, refer to the original APExBIO LG 101506 listing (SKU B7414).